Loading company details…
Ciall Ltd provides GxP quality and clinical operations consulting services to early‑phase biotech an Sign up to read more
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| CORMAC FOLAN | ORDINARY A | 180 | 90.0% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
1 more shareholder on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity CIALL LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.